NVYTF (Novacyt) Other Current Payables: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVYTF Novacyt SA NVYTF
33 GF Score
Price $0.48
GF Value $0.79
! 4 Warning Signs
View Full Analysis

What is Novacyt Other Current Payables?

Novacyt NVYTF -5.90% 33 Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus rates NVYTF with a GF Score™ of 33/100 and a GF Value™ of $0.79. The stock has 4 warning signs investors should review.

Novacyt's Other Current Payables for the quarter that ended in Dec. 2025 was $0.00 Mil.

Novacyt's quarterly Other Current Payables declined from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($-0.00 Mil) but then increased from Jun. 2025 ($-0.00 Mil) to Dec. 2025 ($0.00 Mil).

Novacyt's annual Other Current Payables declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) and declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

Novacyt Other Current Payables Related Terms

Novacyt Other Current Payables Historical Data

* Premium members only.

The historical data trend for Novacyt's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novacyt Other Current Payables Chart

Novacyt Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.00 0.00

Novacyt Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.00 0.00
NVYTF
33GF Score
Novacyt SA NVYTF
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novacyt Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Novacyt (NVYTF) has a Other Current Payables of $0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Novacyt and its competitors.
Is Novacyt's Other Current Payables too high?
Novacyt's current Other Current Payables is $0.00 Mil. Overall, Novacyt has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Novacyt's Other Current Payables compare to ABT and SYK?
Novacyt's Other Current Payables of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Novacyt and its competitors. Novacyt's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novacyt stock overvalued right now?
Novacyt (NVYTF) has a current Other Current Payables of $0.00 Mil. The stock's GF Value™ is $0.79, compared to a current price of $0.48 — trading 39.3% below its estimated fair value. The current Other Current Payables is $0.00 Mil. Novacyt's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Novacyt (NVYTF), the current Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novacyt (NVYTF) Overvalued in 2026?

Based on GuruFocus' analysis, Novacyt stock appears to be undervalued. The current stock price of $0.48 is trading 39.3% below its estimated GF Value™ of $0.79.

Key valuation signals for NVYTF:

  • Other Current Payables: $0.00 Mil
  • GF Value™: $0.79 vs. price of $0.48 (39.3% below fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the NVYTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novacyt Business Description

Address 131 Boulevard Carnot, Le Vesinet, FRA, 78110
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
33GF Score

Get the complete analysis for NVYTF

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price
$0.79
GF Value